Journal article

Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies

Robert Campbell, Geoffrey Chong, Eliza A Hawkes

Journal of Clinical Medicine | MDPI | Published : 2018

Grants

Funding Acknowledgements

Geoff Chong: Research funding: Bristol-Myers Squibb, Merck Serono, Novartis, Pharmacyclics, Hutchison MediPharma, Incyte, Bayer; Eliza Hawkes: Consultation/advisory role-Janssen, Bristol-Myers Squibb, Celgene. Research funding: Merck Serono, Merck Sharpe & Dohme, Bristol-Myers Squibb, Celgene.